Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;34(1):e14595.
doi: 10.1111/dth.14595. Epub 2020 Dec 3.

Generalized pustular psoriasis following COVID-19

Mohammad Shahidi Dadras  1 , Reem Diab  1 , Mahsa Ahadi  2 , Fahimeh Abdollahimajd  1   3
Affiliations

Generalized pustular psoriasis following COVID-19

Mohammad Shahidi Dadras et al. Dermatol Ther. 2021 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Widespread pustules on a background of erythrodermic skin in the patient before treatment (A‐C). Psoriasiform acanthosis; absence of the granular layer with large intraepidermal pustule formation; some tortuous vessels and perivascular lymphocytic and neutrophilic infiltration are seen in the superficial dermis; there is no evidence of viral cytopathic effects (D, H&E ×200; E, H&E ×400). Bilateral ground‐glass opacities and consolidations compatible with COVID‐19 (F, G)
FIGURE 2
FIGURE 2
Marked improvement in the pustular lesions and erythema 2 weeks after treatment with acitretin (A, B)
See this image and copyright information in PMC

Comment in

References

    1. Mirza HA, Badri T, Kwan E. Generalized pustular psoriasis. [Updated 2020 Sep 15. StatPearls [Internet. Treasure Island, FL: StatPearls Publishing; 2020. https://www.ncbi.nlm.nih.gov/books/NBK493189/. - PubMed
    1. Abdelmaksoud A, Goldust M, Vestita M. Comment on “COVID‐19 and psoriasis: is it time to limit treatment with immunosuppressants? A call for action”. Dermatol Ther. 2020;33(4):e13360. - PMC - PubMed
    1. Abdollahimajd F, Niknezhad N, Haghighatkhah HR, Namazi N, Niknejad N, Talebi A. Angiotensin‐converting enzyme and subclinical atherosclerosis in psoriasis: is there any association? A case‐control study. J Am Acad Dermatol. 2020;82(4):980‐981. - PubMed
    1. Kutlu O, Metin A. A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID‐19: will cases of psoriasis increase after COVID‐19 pandemic? Dermatol Ther. 2020;33(4):e13383. - PMC - PubMed
    1. Sachdeva M, Mufti A, Maliyar K, Lytvyn Y, Yeung J. Hydroxychloroquine effects on psoriasis: a systematic review and a cautionary note for COVID‐19 treatment. J Am Acad Dermatol. 2020;83(2):579‐586. - PMC - PubMed